Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 9Lymphoid 7Other hematologic neoplasm 6Plasma cell 3Myeloid 3Head & Neck 2Genitourinary 2Gastrointestinal 2CNS 2Breast 2Thoracic 1Other solid neoplasm 1Other 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Obesity 410Neoplasms 151Mucositis 128Sexual Dysfunction, Physiological 105Breast Neoplasms 105Polycystic Ovary Syndrome 98Overweight 98Dyspnea 62Constipation 57Motor Activity 54Head and Neck Neoplasms 47Prostatic Neoplasms 42Weight Loss 39Diabetes Mellitus 36Pain 34Colorectal Neoplasms 33Endometrial Neoplasms 29Stomatitis 28Opioid-Induced Constipation 28Lung Neoplasms 28Depression 26Diabetes Mellitus, Type 2 24Cardiovascular Diseases 23Obesity, Morbid 22Multiple Endocrine Neoplasia Type 1 22Insulin Resistance 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Anxiety Disorders 21Hypertension 19Sexual Dysfunctions, Psychological 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
beta-Thalassemia × Other × Clear all
NCT06539169 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

xCures

Recruiting
1,000 enrolled
Classical hematologyOtherPlasma cell

Alzheimer Disease, Amyloidosis, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Cystic Fibrosis, Ehlers-Danlos Syndrome, Gaucher Disease, Glycogen Storage Disease Type II, Huntington Disease, Myasthenia Gravis, Gangliosidosis, GM1, alpha-Thalassemia, beta-Thalassemia, Muscular Dystrophy, Duchenne, Insomnia, Fatal Familial, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡